newsfilter
← Latest News
GlobeNewswire·

ImmunityBio Inc. (NASDAQ: IBRX) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.

NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a top complex litigation law firm, is investigating ImmunityBio Inc. (NASDAQ:IBRX) ("ImmunityBio" or the "Company") for potential violations of the